Bristol-Myers Squibb to Take Part in Barclays Global Health Care Conference
Get Alerts BMY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.5%
Revenue Growth %: +3.2%
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at Barclays Global Health Care Conference on Wednesday, March 15, 2017, in Miami. Charles Bancroft, executive vice president and chief financial officer, will answer questions about the company at 8:30 a.m. EDT.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170308005730/en/
Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
Timothy
Power, 609-252-7509
[email protected]
or
Bill
Szablewski, 609-252-5894
[email protected]
Source: Bristol-Myers Squibb Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMS presents five-year Camzyos data for heart condition at ESC
- InvestorNewsBreaks – NurExone Biologic Inc. (TSX.V: NRX) (OTCQB: NRXBF) to Highlight Exosome Technology, Pipeline and US Initiatives at NY Conference
- A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Barclays, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share